Company intelligence / Profile preview

Torque Therapeutics

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Torque Therapeutics developed a platform to modulate immune cell subsets and aimed to address intractable cancers, especially solid tumors, using cell-based immunotherapies, with primary programs in preclinical stages before being acquired and merged into Repertoire Immune Medicines.

Therapeutic areas: HematologyOncology
Modalities: Cell therapyT-lymphocyte cell therapyBiologic
Industry: Biotech

Partnerships

Flagship Pioneering

Beyond the preview

Go deeper on Torque Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torque Therapeutics.

Explore the full profile